Related Experiment Video
Updated: Dec 18, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Oral preexposure prophylaxis continuation, measurement and reporting
Kayla Stankevitz1, Hannah Grant2, Josie Lloyd
1FHI 360, Durham, North Carolina, USA.
Oral pre-exposure prophylaxis (PrEP) continuation is crucial for effectiveness. This review found high early discontinuation and inconsistent reporting, highlighting a need for standardized measurement of PrEP use.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- HIV Prevention
Background:
- Oral pre-exposure prophylaxis (PrEP) is a key strategy for HIV prevention.
- Understanding PrEP continuation is vital for effective rollout and impact monitoring.
- Current methods for measuring PrEP continuation lack standardization.
Purpose of the Study:
- To review and analyze data on PrEP continuation.
- To document how PrEP continuation is reported across studies.
- To compare PrEP continuation rates over time and across different populations.
Main Methods:
- Systematic review and meta-analysis of studies reporting primary data on PrEP continuation.
- Searched MEDLINE, Embase, Global Health, and HIV conference abstracts (2017-2018).
- Summarized findings along a PrEP cascade, presenting continuation at 1, 6, and 12 months.
Main Results:
- 41 studies covering 22,034 individuals were included.
- Continuation data were measured and reported inconsistently.
- High discontinuation was observed at month 1 (66%), with persistent declines over time. Pooled estimates: Month 1: 66%, Month 6: 63%, Month 12: 71%.
Conclusions:
- High early discontinuation suggests PrEP initiation alone is insufficient to gauge effectiveness.
- Declining continuation over time indicates limitations of current cross-sectional indicators.
- There is a critical need for consistent measurement and consensus on PrEP continuation.
More Related Videos
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
19:57An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Methods of Documentation II: POMR
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Drug Analysis Methods
Measurement of Bioavailability: Pharmacodynamic Methods